Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HER2-positive cancer companion diagnostic - Roche Tissue Diagnostics

Next Previous
Search
Drug Profile

HER2-positive cancer companion diagnostic - Roche Tissue Diagnostics

Alternative Names: Pertuzumab companion diagnostic - Roche Tissue Diagnostics; Trastuzumab companion diagnostic - Roche Tissue Diagnostics; Trastuzumab emtansine companion diagnostic - Roche Tissue Diagnostics; Ventana HER2 (4B5) IHC companion diagnostic assay; Ventana HER2/neu (4B5) Rabbit Monoclonal Primary Antibody Assay

Latest Information Update: 13 Jul 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ventana Medical Systems
  • Developer Roche Tissue Diagnostics; Ventana Medical Systems
  • Class Antibody diagnostics
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Gastric cancer; HER2 positive breast cancer

Most Recent Events

  • 13 Jul 2021 Ventana Medical Systems is now called Roche Tissue Diagnostics
  • 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in HER2-positive-breast-cancer (Diagnosis) in Canada
  • 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in HER2-positive-breast-cancer (Diagnosis) in European Union

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top